Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT
Clinical trial NCT02786485 · WITHDRAWN
Trial details
- NCT number
- NCT02786485
- Sponsor
- Bellicum Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2018-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.